DK0868526T3 - Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2 - Google Patents

Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2

Info

Publication number
DK0868526T3
DK0868526T3 DK96942085T DK96942085T DK0868526T3 DK 0868526 T3 DK0868526 T3 DK 0868526T3 DK 96942085 T DK96942085 T DK 96942085T DK 96942085 T DK96942085 T DK 96942085T DK 0868526 T3 DK0868526 T3 DK 0868526T3
Authority
DK
Denmark
Prior art keywords
acetyl
paph
amidinophenylalanine
palme
cyanophenylalanine
Prior art date
Application number
DK96942085T
Other languages
Danish (da)
English (en)
Inventor
Chi-Hsin R King
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0868526T3 publication Critical patent/DK0868526T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cosmetics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK96942085T 1995-12-20 1996-11-25 Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2 DK0868526T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57556995A 1995-12-20 1995-12-20
PCT/US1996/019005 WO1997022712A1 (en) 1995-12-20 1996-11-25 NOVEL PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-β-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH¿2?

Publications (1)

Publication Number Publication Date
DK0868526T3 true DK0868526T3 (da) 2002-12-02

Family

ID=24300839

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942085T DK0868526T3 (da) 1995-12-20 1996-11-25 Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2

Country Status (27)

Country Link
EP (1) EP0868526B1 (xx)
JP (1) JP4044614B2 (xx)
KR (1) KR100438879B1 (xx)
CN (1) CN1087349C (xx)
AR (1) AR005119A1 (xx)
AT (1) ATE222293T1 (xx)
AU (1) AU717995B2 (xx)
BR (1) BR9612059A (xx)
CA (1) CA2241210C (xx)
CZ (1) CZ295362B6 (xx)
DE (1) DE69623038T2 (xx)
DK (1) DK0868526T3 (xx)
EE (1) EE03698B1 (xx)
ES (1) ES2179957T3 (xx)
HK (1) HK1017384A1 (xx)
IL (1) IL125003A (xx)
MX (1) MX9804997A (xx)
NO (1) NO319678B1 (xx)
NZ (1) NZ324159A (xx)
PL (1) PL185541B1 (xx)
PT (1) PT868526E (xx)
RU (1) RU2170764C2 (xx)
SK (1) SK281432B6 (xx)
TR (1) TR199801107T2 (xx)
UA (1) UA48993C2 (xx)
WO (1) WO1997022712A1 (xx)
ZA (1) ZA9610600B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL349343A1 (en) 1999-01-02 2002-07-15 Aventis Pharma Gmbh Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity)
EP1016663A1 (en) * 1999-01-02 2000-07-05 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)
RU2250212C2 (ru) * 2000-01-28 2005-04-20 Авентис Фарма Дойчланд Гмбх Способ получения ацетиламидиниофенилаланилциклогексилглицилпиридиниоаланинамидов
EP1127884A1 (en) 2000-02-26 2001-08-29 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
WO2004050637A2 (en) 2002-12-03 2004-06-17 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
GB0306267D0 (en) * 2003-03-19 2003-04-23 Ineos Fluor Ltd Process
JP2008260755A (ja) * 2007-03-20 2008-10-30 Sumitomo Chemical Co Ltd Ｌ−ビフェニルアラニン化合物の塩の回収方法、およびそれを用いたビフェニルアラニンエステル化合物の回収方法
CN106946724B (zh) * 2017-04-07 2019-03-22 苏州汉德创宏生化科技有限公司 单胺基抑制剂类中间体2-乙酰氨基-2-苄基丙二酸单乙酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981799A (en) * 1987-08-21 1991-01-01 Takeda Chemical Industries, Ltd. Acylamino acid racemase, production and use thereof
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
AU662522B2 (en) * 1991-05-13 1995-09-07 Fujisawa Pharmaceutical Co., Ltd. New peptide compound and a process for the preparation thereof
SI9520044B (sl) * 1994-04-26 2004-08-31 Aventis Pharmaceuticals Inc. Inhibitorji Xa faktorja

Also Published As

Publication number Publication date
DE69623038T2 (de) 2002-12-12
CZ195698A3 (cs) 1999-01-13
CN1087349C (zh) 2002-07-10
SK85598A3 (en) 1998-12-02
TR199801107T2 (xx) 1998-10-21
MX9804997A (es) 1998-09-30
DE69623038D1 (de) 2002-09-19
EP0868526B1 (en) 2002-08-14
PT868526E (pt) 2002-12-31
ES2179957T3 (es) 2003-02-01
IL125003A0 (en) 1999-01-26
KR100438879B1 (ko) 2004-07-16
AU1125197A (en) 1997-07-14
PL327314A1 (en) 1998-12-07
WO1997022712A1 (en) 1997-06-26
NO982868L (no) 1998-08-19
AR005119A1 (es) 1999-04-14
JP2000501618A (ja) 2000-02-15
ATE222293T1 (de) 2002-08-15
CZ295362B6 (cs) 2005-07-13
CA2241210C (en) 2002-05-14
CA2241210A1 (en) 1997-06-26
RU2170764C2 (ru) 2001-07-20
SK281432B6 (sk) 2001-03-12
BR9612059A (pt) 1999-02-23
NZ324159A (en) 1999-07-29
NO319678B1 (no) 2005-09-05
AU717995B2 (en) 2000-04-06
IL125003A (en) 2001-12-23
UA48993C2 (uk) 2002-09-16
JP4044614B2 (ja) 2008-02-06
CN1205742A (zh) 1999-01-20
PL185541B1 (pl) 2003-05-30
ZA9610600B (en) 1997-06-20
KR20000064486A (ko) 2000-11-06
EE03698B1 (et) 2002-04-15
EE9800188A (et) 1998-12-15
EP0868526A1 (en) 1998-10-07
NO982868D0 (no) 1998-06-19
HK1017384A1 (en) 1999-11-19

Similar Documents

Publication Publication Date Title
DK0833649T3 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf
AU1087497A (en) Clamp assembly and method of use
ZA964733B (en) Ob protein compositions and methods
IL117409A0 (en) Flow electroporation chamber and method
EP1037911A4 (en) ANTI-PATHOGEN SYSTEM AND METHOD FOR USE THEREOF
NO974494L (no) Radiomerkede peptider for diagnostikk og terapi
EP0998324A4 (en) VASCULAR SHUTTERING APPARATUS AND RELATED METHOD
NO972096D0 (no) Apparat og fremgangsmåte for forlengning og fortykkelse av hår og for festing av hårstykker
ZA969444B (en) Peptides which enhance transport across tissues and methods of identifying and using the same
GB2299913B (en) Telephony system and method
US5656608B1 (en) Amino acid compositions and methods of treatment using same
ZA967819B (en) Methods and compositions for controlling biofouling using amides
DK0839153T3 (da) Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider
EP0779325A3 (en) Pourous film and preparation process thereof
DK0868526T3 (da) Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2
DK0947079T3 (da) System og fremgangsmåder til internettelefoni
NO960847D0 (no) System med fortöyning og forbindelsesledning
ZA96240B (en) Novel peptides their preparation and use
DK1043332T3 (da) Dipeptider indeholdende cyclopentan-beta-aminosyrer
GB9523497D0 (en) Cell membrane protein and application thereof
SI0868526T1 (en) PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-BETA-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH2
ZA978220B (en) PTX-sensitive G proteins their preparation and use
DE69832485D1 (de) Verfahren zur gleichzeitigen herstellung von isomaltulose (und/oder trehalulose) und betaine
AU2589497A (en) Constrained cd4 peptides and methods of using the same
GB9505787D0 (en) Apparatus and method for clip application